Skip to main content
logo
Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
5.87
-0.34 (-5.48%)
At close: Oct 8, 2025, 4:00 PM EDT
5.85
-0.02 (-0.34%)
After-hours: Oct 8, 2025, 6:33 PM EDT

Company Description

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets.

The company was founded in 2017 and is based in Cambridge, Massachusetts.

Vyome Holdings, Inc.
Vyome Holdings logo
CountryUnited States
Founded2017
IndustryBiotechnology
SectorHealthcare
Employees18
CEOVenkateswarlu Nelabhotla

Contact Details

Address:
Harvard Square, One Mifflin Place
Cambridge, Massachusetts 02138
United States
Phone973-832-8147
Websitevyometx.com

Stock Details

Ticker SymbolHIND
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001371217
Employer ID48-1293684
SIC Code3845

Key Executives

NamePosition
Venkateswarlu Nelabhotla M.B.A.Co-Founder, Chief Executive Officer, President and Director
Dr. Shiladitya Sengupta M.Sc., Ph.D.Co-Founder, Director and Member of Scientific and Clinical Advisory Board
Dr. Richard Fahrner Ph.D.Chief Technology Officer
Dr. Angelo Secci M.D.Chief Medical Officer
Dr. Charles G. Chavdarian Ph.D.Senior Vice President of Product Development and Regulatory CMC
Dr. Rena Patel J.D., Ph.D.Chief Patent Counsel
Dr. Tamara Agajanov M.D.Senior Vice President of Clinical Development

Latest SEC Filings

DateTypeTitle
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
Jun 25, 2021EFFECTNotice of Effectiveness
View All SEC Filings